Zacks Research Forecasts Reduced Earnings for Select Medical

Select Medical Holdings Co. (NYSE:SEM) – Investment analysts at Zacks Research lowered their Q4 2024 EPS estimates for shares of Select Medical in a research note issued on Thursday, November 14th. Zacks Research analyst Z. Masood now expects that the health services provider will post earnings of $0.30 per share for the quarter, down from their prior forecast of $0.31. The consensus estimate for Select Medical’s current full-year earnings is $2.16 per share. Zacks Research also issued estimates for Select Medical’s Q1 2025 earnings at $0.62 EPS, Q2 2025 earnings at $0.59 EPS, Q4 2025 earnings at $0.47 EPS, FY2025 earnings at $2.14 EPS, Q3 2026 earnings at $0.56 EPS and FY2026 earnings at $2.44 EPS.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the company posted $0.46 earnings per share. Select Medical’s revenue for the quarter was up 5.7% on a year-over-year basis.

A number of other analysts have also recently issued reports on the stock. Benchmark reissued a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 13th. Royal Bank of Canada upped their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, Bank of America initiated coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $40.75.

Select Medical Price Performance

NYSE SEM opened at $37.45 on Monday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 12 month low of $22.26 and a 12 month high of $40.98. The stock has a market cap of $4.85 billion, a price-to-earnings ratio of 17.50, a PEG ratio of 1.95 and a beta of 1.42. The company’s 50 day moving average is $34.81 and its two-hundred day moving average is $34.77.

Hedge Funds Weigh In On Select Medical

Institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its position in shares of Select Medical by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after acquiring an additional 46,880 shares during the last quarter. Barclays PLC raised its stake in Select Medical by 396.0% during the third quarter. Barclays PLC now owns 192,357 shares of the health services provider’s stock valued at $6,707,000 after purchasing an additional 153,576 shares in the last quarter. XTX Topco Ltd bought a new position in Select Medical during the third quarter valued at $580,000. Jane Street Group LLC grew its stake in shares of Select Medical by 14.2% in the 3rd quarter. Jane Street Group LLC now owns 127,504 shares of the health services provider’s stock worth $4,446,000 after buying an additional 15,827 shares in the last quarter. Finally, Quarry LP bought a new stake in shares of Select Medical in the 3rd quarter worth about $30,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be given a dividend of $0.125 per share. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.34%. Select Medical’s payout ratio is 23.36%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.